Si Vega Hospital Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.10 Cr
as on 17-07-2024
- Satisfied Charges ₹ 9.70 M
as on 17-07-2024
- Revenue -17.89%
(FY 2023)
- Profit -62.10%
(FY 2023)
- Ebitda -59.60%
(FY 2023)
- Net Worth 1.36%
(FY 2023)
- Total Assets 11.88%
(FY 2023)
About Si Vega Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹10.10 Cr. The company has closed loans amounting to ₹9.70 M, as per Ministry of Corporate Affairs (MCA) records.
Vundavalli Suriraju and Katta Indraja serve as directors at the Company.
- CIN/LLPIN
U74900KA2014PTC075708
- Company No.
075708
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Si Vega Hospital?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vundavalli Suriraju  | Director | 07-Aug-2014 | Current |
| Katta Indraja | Director | 07-Aug-2014 | Current |
Financial Performance of Si Vega Hospital.
Si Vega Hospital Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.89% decrease. The company also saw a substantial fall in profitability, with a 62.1% decrease in profit. The company's net worth moved up by a moderate rise of 1.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Si Vega Hospital?
In 2023, Si Vega Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Si Hospital Private LimitedActive 17 years 4 monthsVundavalli Suriraju and Katta Indraja are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Sep 2023 | ₹10.10 Cr | Open |
Syndicate Bank Creation Date: 18 Dec 2014 | ₹9.70 M | Satisfied |
How Many Employees Work at Si Vega Hospital?
Si Vega Hospital has a workforce of 63 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Si Vega Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Si Vega Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
